International Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 2 Year, 1 Month
About International Drugs And Pharmaceuticals
International Drugs And Pharmaceuticals Limited (IDAPL) is a Public Limited Indian Non-Government Company incorporated in India on 04 January 2023 (Two years and one month 4 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Tanishq, Usha Bhutani, and Rakesh Bhutani serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290UR2023PLC015126
-
Company No.
015126
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
04 Jan 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at International Drugs And Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanishq
|
Director | 04-Jan-2023 | Current |
|
Usha Bhutani
|
Director | 04-Jan-2023 | Current |
|
Rakesh Bhutani
|
Director | 04-Jan-2023 | Current |
Financial Performance of International Drugs And Pharmaceuticals.
Enhance accessibility to International Drugs And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of International Drugs And Pharmaceuticals?
Unlock access to International Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Elder Remedies LimitedTanishq is a mutual person
-
Elder Health Science LimitedTanishq is a mutual person
-
Elder Biocare Private Limited
Tanishq is a mutual person
-
Radicon Pharmaceuticals Limited
Tanishq and Rakesh Bhutani are mutual person
-
Elder Bioscience Private Limited
Usha Bhutani and Rakesh Bhutani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at International Drugs And Pharmaceuticals?
International Drugs And Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of International Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped International Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.